Security key
825693500
Shuttle Pharmaceuticals Holdings, Inc. - COMMON STOCK (SHPH)
CUSIP: 825693500
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 14,715
- Total 13F value
- $59,448
- Share change
- +14,715
- SEC-reported price per share
- $4.04
- Number of holders
- 1
- Value change
- +$59,448
- Number of buys
- 1
Report period
Q3 2026
Institutions
1
Top holders
1
SHPH full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q2 2026
Shuttle Pharmaceuticals Holdings, Inc. SEC filings
Shuttle Pharmaceuticals Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 825693500
Recent filing periods:
Ownership snapshot
Top reported holders of SHPH - Shuttle Pharmaceuticals Holdings, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
Mira Jung
Comparable rows
1/15
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 5%
14 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 1
ARMISTICE CAPITAL, LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
Reported 13D/G
· 30 Jun 2025
|
$222,136
56,237 shares
|
$0 | 30 Jun 2025 |
| Anatoly Dritschilo |
3/4/5
CEO and Chairman, Director, 10%+ Owner
|
—
denominator unverified
|
$1,484,281
3,204,407 shares
|
— | 14 Aug 2023 |
| Mira Jung |
3/4/5
Chief Scientific Officer
|
—
denominator unverified
|
$1,530,865
135,715 shares
|
— | 01 May 2024 |
| HRT FINANCIAL LP |
13F
Company
|
—
denominator unverified
|
$255,000
78,597 shares
|
— | 30 Jun 2026 |
| Milton Brown |
3/4/5
Director
|
—
denominator unverified
|
$160,553
346,617 shares
|
— | 31 Dec 2024 |
| Steven M. Richards |
3/4/5
Director
|
—
mixed-class rows
|
$97,274
239,244 shares
mixed-class rows
|
— | 08 Aug 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
14,715
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
5
Q3 2026 holders
1
Holder diff
-4
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend